Micheal O'Donnell

11PUBLICATIONS
36CO-AUTHORS
Predictive and prognostic markersCancer cell biologyCancer therapy (excl. chemotherapy and radiation therapy)Medical roboticsHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|May 28, 2026
Computed tomography-derived extracellular volume fraction is associated with high-grade recurrence in non-muscle-invasive bladder cancer treated with intravesical gemcitabine and docetaxel.

|Apr 28, 2026
'BJUI Clinical Dilemma': Recurrent high-grade non-muscle-invasive bladder cancer in 2026.

|Apr 01, 2026
Active surveillance in low-grade NMIBC - results of an international two-round modified Delphi consensus.

Roberto Contieri, Paolo Gontero, Rodolfo Hurle

|Jan 19, 2026
Impact of American Urological Association risk category on outcomes of intravesical BCG vs gemcitabine/docetaxel in high-grade Ta non-muscle-invasive bladder cancer.

Mohamad Abou Chakra, Ian M McElree, Sarah L Mott

|Nov 03, 2025
Drug-releasing intravesical floating technology for sequential gemcitabine and docetaxel in non-muscle-invasive bladder cancer.

Ashley C Rhodes, Kaitlyn A McClintic, Emily Witt

|Oct 22, 2025
Long-term outcomes of a cascading salvage strategy for high-risk non-muscle-invasive bladder cancer.

Ian M McElree, Ryan L Steinberg, Helen Y Hougen

Pageof 2

Frequent Collaborators

4 joint publications

Ian McElree

3 joint publications

Vignesh T Packiam

3 joint publications

Yair Lotan

2 joint publications

Jeremy Yc Teoh